封面
市場調查報告書
商品編碼
1315753

骨科生物製劑市場:按類型、用途和最終用戶分類 - 2023-2030 年全球預測

Orthobiologics Market by Type, Application, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2023 年,全球骨科生物製品市場將達到 66.1425 億美元,年複合成長率為 6.71%,預計到 2030 年將成長至驚人的 104.3631 億美元。

FPNV定位矩陣

FPNV 定位矩陣對於評估全球骨科生物製品市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標,我們對供應商進行全面評估,使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限,並取得了不同程度的成功:前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻,可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解:

1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。

2. 市場開發:提供有關利潤豐厚的新興市場的詳細資訊,並分析其在成熟市場的滲透率。

3. 市場多元化:提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢:全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題:

1.骨科生物製劑的全球市場規模與預測為何?

2. 在預測期內,COVID-19 對全球骨科生物製品市場的阻礙因素與影響有哪些?

3. 在預測期內,全球骨科生物製品市場需要投資哪些產品/細分市場/應用/領域?

4.骨科生物製劑在全球市場的競爭策略為何?

5. 全球骨科生物製品市場的技術趨勢和法律規範是什麼?

6. 全球骨科生物製品市場主要供應商的市佔率為何?

7. 哪些型態和策略措施被認為適合進入全球骨科生物製品市場?

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 世界各地易患各種疾病的老年人數量正在迅速增加。
      • 提高對骨科生物學的認知
      • 肥胖症迅速增加,體育和交通事故增加
    • 抑制因素
      • 骨科生物製劑價格昂貴
    • 機會
      • 開發中國家的高成長潛力
      • 對先進治療的需求不斷成長
    • 任務
      • 嚴格的核准流程
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 骨科生物製劑市場:依類型

  • 同種異體移植物
  • 骨形成蛋白
  • 去礦骨基質
  • 關節液體治療
  • 軟組織修復
  • 幹細胞療法
  • 合成骨移植物

第7章 骨科生物製品市場:依用途

  • 骨折恢復
  • 重建手術
  • 軟組織損傷
  • 脊椎融合手術
  • 創傷修復

第8章 骨科生物製品市場:依最終使用者分類

  • 牙科診所和設施
  • 醫院
  • 研究和學術機構

第9章 美洲骨科生物製品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區骨科生物製品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的骨科生物製品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析:主要企業
  • 競爭情境分析:主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-036C5CF3B4C4

The Global Orthobiologics Market is forecasted to grow significantly, with a projected USD 6,614.25 million in 2023 at a CAGR of 6.71% and expected to reach a staggering USD 10,436.31 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Orthobiologics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Orthobiologics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Allografts, Bone Morphogenic Proteins, Demineralised Bone Matrix, Joint Fluid Therapy, Soft Tissue Repair, Stem Cell Therapies, and Synthetic Bone Grafts. The Joint Fluid Therapy is projected to witness significant market share during forecast period.

Based on Application, market is studied across Fracture Recovery, Reconstructive Surgery, Soft-Tissue Injuries, Spinal Fusion, and Trauma Repair. The Reconstructive Surgery is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Dental Clinics & Facilities, Hospitals, and Research & Academic Institutes. The Dental Clinics & Facilities is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Orthobiologics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Orthobiologics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Orthobiologics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Orthobiologics Market?

4. What is the competitive strategic window for opportunities in the Global Orthobiologics Market?

5. What are the technology trends and regulatory frameworks in the Global Orthobiologics Market?

6. What is the market share of the leading vendors in the Global Orthobiologics Market?

7. What modes and strategic moves are considered suitable for entering the Global Orthobiologics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Orthobiologics Market, by Type, 2022 vs 2030
  • 4.3. Orthobiologics Market, by Application, 2022 vs 2030
  • 4.4. Orthobiologics Market, by End-User, 2022 vs 2030
  • 4.5. Orthobiologics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in geriatric population across the globe prone with various diseases
      • 5.1.1.2. Increase in awareness of orthobiologics
      • 5.1.1.3. Surge in obesity and rise in number of sports accidents and road accidents
    • 5.1.2. Restraints
      • 5.1.2.1. Higher cost of orthobiologics
    • 5.1.3. Opportunities
      • 5.1.3.1. High growth potential in developing nations
      • 5.1.3.2. Upsurge in demand for advanced treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent approval process
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Orthobiologics Market, by Type

  • 6.1. Introduction
  • 6.2. Allografts
  • 6.3. Bone Morphogenic Proteins
  • 6.4. Demineralised Bone Matrix
  • 6.5. Joint Fluid Therapy
  • 6.6. Soft Tissue Repair
  • 6.7. Stem Cell Therapies
  • 6.8. Synthetic Bone Grafts

7. Orthobiologics Market, by Application

  • 7.1. Introduction
  • 7.2. Fracture Recovery
  • 7.3. Reconstructive Surgery
  • 7.4. Soft-Tissue Injuries
  • 7.5. Spinal Fusion
  • 7.6. Trauma Repair

8. Orthobiologics Market, by End-User

  • 8.1. Introduction
  • 8.2. Dental Clinics & Facilities
  • 8.3. Hospitals
  • 8.4. Research & Academic Institutes

9. Americas Orthobiologics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Orthobiologics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Orthobiologics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ORTHOBIOLOGICS MARKET RESEARCH PROCESS
  • FIGURE 2. ORTHOBIOLOGICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. ORTHOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. ORTHOBIOLOGICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. ORTHOBIOLOGICS MARKET DYNAMICS
  • FIGURE 9. ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ORTHOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. ORTHOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. ORTHOBIOLOGICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. ORTHOBIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. ORTHOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. ORTHOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENIC PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ORTHOBIOLOGICS MARKET SIZE, BY DEMINERALISED BONE MATRIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ORTHOBIOLOGICS MARKET SIZE, BY JOINT FLUID THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ORTHOBIOLOGICS MARKET SIZE, BY SOFT TISSUE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ORTHOBIOLOGICS MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ORTHOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. ORTHOBIOLOGICS MARKET SIZE, BY FRACTURE RECOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ORTHOBIOLOGICS MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ORTHOBIOLOGICS MARKET SIZE, BY SOFT-TISSUE INJURIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ORTHOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ORTHOBIOLOGICS MARKET SIZE, BY TRAUMA REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. ORTHOBIOLOGICS MARKET SIZE, BY DENTAL CLINICS & FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ORTHOBIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ORTHOBIOLOGICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ORTHOBIOLOGICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM ORTHOBIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM ORTHOBIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. ORTHOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 150. ORTHOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 151. ORTHOBIOLOGICS MARKET LICENSE & PRICING